NDC 63187-256 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC63187-256

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Proficient Rx LP
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA078152
Marketed since
June 27, 2007
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (8)

Package NDCDescriptionSince
63187-256-044 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-04)Sep 19, 2024
63187-256-055 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-05)Dec 28, 2022
63187-256-066 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-06)Jan 24, 2024
63187-256-1010 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-10)Dec 28, 2022
63187-256-1212 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-12)Mar 26, 2024
63187-256-1515 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-15)Dec 28, 2022
63187-256-2020 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-20)Jun 1, 2017
63187-256-3030 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (63187-256-30)Jun 1, 2017

Other Ondansetron products